Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
Variations in serum molecular forms of prolactin (PRL) from an adolescent woman presenting amenorrhea-galactorrhea are reported. Persistent hyperprolactinemia and hypoestrogenism were demonstrated as well as the presence of a pituitary tumor with suprasellar extension. Bromocriptine was given at progressive doses up to 37 mg daily, decreasing the hyperprolactinemia and galactorrhea. After 2 years of treatment the patient noticed symptoms of gastric intolerance, bromocriptine was discontinued and a rebound of hyperprolactinemia was observed. Lisuride was administered instead resulting in a new decrease in PRL serum levels, disappearance of galactorrhea and beginning of regular menses. Serum gel chromatographic analysis was carried out before and during lisuride treatment. The first chromatographic analysis showed a predominance of high molecular weight (approximately 66 KD) PRL, accounting for more than 90% of the immunoreactive PRL. The second chromatography showed the major peak of immunoreactive PRL displaced to the right (molecular weight of 22 KD), which was eluted near the PRL standard. With these chromatographic patterns it is concluded that the pituitary macroprolactinoma secreted different molecular forms of PRL and treatment with lisuride appeared to exert some effect on the PRL molecular size secreted by the pituitary.
Morán
C
C
Endocrine Research Unit, Hospital Luis Castelazo Ayala, Instituto Mexicano del Seguro Social, México, D.F.
Tena
G
G
Fonseca
M E
ME
Ochoa
R
R
Bermúdez
J A
JA
Zárate
A
A
D000293:Adolescent; D000568:Amenorrhea / Q000188:drug therapy / Q000209:etiology; D001971:Bromocriptine / Q000627:therapeutic use; D005260:Female; D005687:Galactorrhea / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D006966:Hyperprolactinemia / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D008090:Lisuride / Q000627:therapeutic use; D008970:Molecular Weight; D010911:Pituitary Neoplasms / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000378:metabolism*; D011388:Prolactin / Q000097:blood* / Q000145:classification / Q000378:metabolism; D015175:Prolactinoma / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000378:metabolism*; D011859:Radiography
D001971:Bromocriptine; D011388:Prolactin; D008090:Lisuride